Latanoprost (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Latanoprost" in German language version.

refsWebsite

Global rank German rank

4^th place

7^th place

2^nd place

3^rd place

low place

924^th place

87^th place

800^th place

160^th place

doi.org

S. S. Patel, C. M. Spencer: Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension. In: Drugs Aging. 9. Jahrgang, Nr. 5, 1996, S. 363–378, doi:10.2165/00002512-199609050-00007, PMID 8922563.
Kristiina M. Huttunen, Hannu Raunio, Jarkko Rautio: Prodrugs—from Serendipity to Rational Design. In: Pharmacological Reviews. Band 63, Nr. 3, 9. Januar 2011, S. 750–771, doi:10.1124/pr.110.003459, PMID 21737530.
W. Y. Zhang, A. L. Wan Po, H. S. Dua, A. Azuara-Blanco: Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. In: British Journal of Ophthalmology. 85. Jahrgang, 2001, S. 983–990, doi:10.1136/bjo.85.8.983, PMID 11466259, PMC 1724079 (freier Volltext).
T. Aung, H. T. Wong, C. C. Yip, J. Y. Leong, Y. H. Chan, P. T. Chew: Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study. In: Ophthalmology. Band 107, Nummer 6, Juni 2000, S. 1178–1183, doi:10.1016/s0161-6420(00)00073-7, PMID 10857840.

Patent US5296504: Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension. Veröffentlicht am 22. März 1994.‌

S. S. Patel, C. M. Spencer: Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension. In: Drugs Aging. 9. Jahrgang, Nr. 5, 1996, S. 363–378, doi:10.2165/00002512-199609050-00007, PMID 8922563.
Kristiina M. Huttunen, Hannu Raunio, Jarkko Rautio: Prodrugs—from Serendipity to Rational Design. In: Pharmacological Reviews. Band 63, Nr. 3, 9. Januar 2011, S. 750–771, doi:10.1124/pr.110.003459, PMID 21737530.
C. M. Perry, J. K. McGavin, C. R. Culy, T. Ibbotson: Latanoprost. An Update of its Use in Glaucoma and Ocular Hypertension. In: Drugs Aging. 20. Jahrgang, Nr. 8, 2003, S. 1170–2229, PMID 12795627.
W. Y. Zhang, A. L. Wan Po, H. S. Dua, A. Azuara-Blanco: Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. In: British Journal of Ophthalmology. 85. Jahrgang, 2001, S. 983–990, doi:10.1136/bjo.85.8.983, PMID 11466259, PMC 1724079 (freier Volltext).
T. Aung, H. T. Wong, C. C. Yip, J. Y. Leong, Y. H. Chan, P. T. Chew: Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study. In: Ophthalmology. Band 107, Nummer 6, Juni 2000, S. 1178–1183, doi:10.1016/s0161-6420(00)00073-7, PMID 10857840.